Status:
COMPLETED
A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects
Lead Sponsor:
Pfizer
Conditions:
Pain
Eligibility:
MALE
21-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the safety and tolerability of PF-03864086 in healthy male human volunteers. Determine the pharmacokinetics (calculations of the rate of elimination of PF-038...
Eligibility Criteria
Inclusion
- healthy male volunteers
- no drug history
- no other medication for 28 pre-dose
Exclusion
- age below 21 years
- age above 55 years
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00747058
Start Date
August 1 2008
End Date
December 1 2008
Last Update
January 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Brussels, Belgium, 1070